zepbound and semaglutide beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs – Zepbound vs Semaglutide vs Wegovy

We absolutely need more data on this because Novo Nordisk has not released any kidney parameters regarding CagriSema as of mid-November 2025, however, they are actively studying it in a trial

You need to bring meaning to every setback

Those considering discontinuing semaglutide should continue probiotics through the transition period, as the microbiome will shift again when GLP-1 signaling returns to baseline levels

over several months meaningful fat loss and body-composition changes tend to show up, if they happen at all

Consider Non-Medical Approaches: Some patients benefit from non-invasive fat reduction techniques or personalized coaching that keeps them accountable and motivated

Demand for Wegovy and Ozempic exploded far beyond Novo Nordisk's manufacturing capacity